Both CA 19.9 and carcinoembryonic antigen (CEA) exhibit reasonable sensitivity for cholangiocarcinoma, with up to 74% for CA 19.9 and 84% for CEA [17]. This evidence concerns the gene CEACAM5 and cholangiocarcinoma.